Philippe P
Department of Social and Preventive Medicine, Faculty of Medicine, University of Montreal, Canada.
J Clin Epidemiol. 1994 Apr;47(4):419-33. doi: 10.1016/0895-4356(94)90163-5.
The objective is to look into the well-known robustness of Sartwell's disease incubation period (IP) lognormal model. A new approach is proposed that embeds the pathogenesis of infection into the framework of percolation theory derived from the physical sciences. A two-step model of the individual disease process is proposed. The first step has a stochastic basis: it is aimed at establishing the threshold position of subjects bound to be diseased. Agent and host factors entertain and help the process reach the threshold. They include all the biologic risk factors (age, exposure dose and intensity, route of inoculation, etc.) to which Sartwell's model is usually found robust. The threshold is the point of no return of the disease process. The threshold provides the initial conditions of the second step. The second step traces the evolution of the pathologic process until disease onset: it is based on a nonlinear deterministic model that progressively unfolds the individual fates. As a chaotic regime is embedded into the model and as chaos unavoidably develops at some time entailing disease onset, the IP distribution becomes independent of the initial conditions laid out at the threshold. Unpredictable disease time courses and onsets are obtained. Biological examples supporting the model are provided. A simulation of 1000 pathologic processes is undertaken according to a simple birth-and-death process of microorganisms or cancer cells. As expected, a lognormal fits the IP distribution over a wide range. A lack of lengthy IPs is, however, observed. A simple multiplicative process coincides exactly with a lognormal model, but a multiplicative-competitive process such as that which is embedded in the nonlinear deterministic model has a narrower distribution. Large sample sizes are, however, needed to uncover this departure from the lognormal. Biologically, at least two phases of the empiric IP should be told apart: lengthy IPs should be distinguished from short and median IPs. Lengthy IPs emphasize interaction (complexity) between the disease progression and the immunological defenses of the host. Simulated distributions involving process complexity closely fit selected cancer data sets. Process complexity of the host pathologic unfolding can actually be recognized and quantified.
目的是研究萨特韦尔疾病潜伏期(IP)对数正态模型广为人知的稳健性。提出了一种新方法,即将感染的发病机制嵌入源自物理科学的渗流理论框架中。提出了个体疾病过程的两步模型。第一步具有随机基础:旨在确定必然患病个体的阈值位置。病原体和宿主因素参与并帮助该过程达到阈值。它们包括所有通常发现萨特韦尔模型对其具有稳健性的生物学风险因素(年龄、暴露剂量和强度、接种途径等)。阈值是疾病过程的不可逆转点。该阈值为第二步提供初始条件。第二步追踪病理过程直至疾病发作的演变:它基于一个非线性确定性模型,该模型逐步展现个体的命运。由于模型中嵌入了混沌状态,且混沌在某个时候不可避免地发展并导致疾病发作,IP分布变得与阈值处设定的初始条件无关。从而获得不可预测的疾病时间进程和发病情况。提供了支持该模型的生物学实例。根据微生物或癌细胞的简单生死过程对1000个病理过程进行了模拟。正如预期的那样,对数正态分布在很宽的范围内拟合IP分布。然而,观察到缺乏长潜伏期。一个简单的乘法过程与对数正态模型完全一致,但诸如嵌入非线性确定性模型中的乘法竞争过程具有更窄的分布。然而,需要大样本量才能发现这种与对数正态分布的偏差。从生物学角度来看,经验性IP的至少两个阶段应该区分开来:长潜伏期应与短和中等潜伏期区分开来。长潜伏期强调疾病进展与宿主免疫防御之间的相互作用(复杂性)。涉及过程复杂性的模拟分布与选定的癌症数据集紧密拟合。宿主病理展开的过程复杂性实际上可以被识别和量化。